Stocklytics Platform
Asset logo for symbol HRTX
Heron Therapeutics
HRTX69
$1.84arrow_drop_down1.60%-$0.03
Penny Stock
Asset logo for symbol HRTX
HRTX69

$1.84

arrow_drop_down1.60%
query_stats

HRTX is not a dividend stock

Therefore Dividends subscore should not be taken into consideration

For certain stocks classified as non-dividend stocks, dividend-related data may not be available or applicable. Non-dividend stocks are those where the company does not regularly distribute dividends to its shareholders.

Why No Data?

Non-dividend stocks typically do not offer regular dividend payments. As a result, there might be no dividend-related information or history for such stocks within our database.

Understanding Non-Dividend Stocks

Non-dividend stocks are characterized by companies that reinvest their profits back into the business for expansion, research, development, or other strategic purposes rather than distributing dividends to shareholders.

What This Means for Investors

Investors in non-dividend stocks often focus on capital appreciation, anticipating the value of their shares to increase over time without relying on dividend income.

Stay Updated

While dividend information may not be available for these stocks, other critical financial metrics and analyses are accessible on Stocklytics to aid in informed investment decisions.

Stock Split History (HRTX)

DateSplitMultipleCumulative
Multiple
Jan 13, 20141:20x0.1x0
May 25, 20071:4x0.2x0.2

Heron Therapeutics (HRTX) Dividends & Splits

Heron Therapeutics Inc (HRTX) does not currently offer a dividend to its shareholders. As a biotechnology company focused on developing and commercializing innovative products for pain management and ophthalmic diseases, Heron Therapeutics has chosen to reinvest its earnings back into research and development. This strategy allows the company to continue its pursuit of new treatment options and advancements in the medical field.
Since its founding, Heron Therapeutics Inc (HRTX) has not undergone any stock splits. The company has maintained a consistent capital structure, with its shares trading at a stable price. Stock splits are typically employed by companies to increase the liquidity of their shares and make them more accessible to a broader range of investors. However, Heron Therapeutics has not found it necessary to implement a split at this time.
add Heron Therapeutics  to watchlist

Keep an eye on Heron Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

When was the last Heron Therapeutics (HRTX) stock split?

Heron Therapeutics (HRTX) has undergone 2 total stock splits. The most recent split was a 1:20 split on 2014 Jan 13, leaving the company with 152.56M shares outstanding. Since the company's inception, the cumulative multiple from splits is 0, indicating the overall effect of all splits on the original share count.
help

Does Heron Therapeutics (HRTX) stock pay dividends?

No, Heron Therapeutics (HRTX) does not pay dividends. This could indicate that the company is currently focusing on reinvesting its earnings into growth opportunities rather than distributing them as dividends.

Take Your Investments to a Whole New Level